These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16222146)

  • 21. Signal transduction pathways and transcriptional mechanisms as targets for prevention of emergence of multidrug resistance in human cancer cells.
    Shtil AA
    Curr Drug Targets; 2001 Mar; 2(1):57-77. PubMed ID: 11465539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenovirus vector covalently conjugated to polyethylene glycol with a cancer-specific promoter suppresses the tumor growth through systemic administration.
    Yao X; Yoshioka Y; Morishige T; Eto Y; Narimatsu S; Mizuguchi H; Mukai Y; Okada N; Nakagawa S
    Biol Pharm Bull; 2010; 33(6):1073-6. PubMed ID: 20522982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in adenovirus-mediated p53 cancer gene therapy.
    Tazawa H; Kagawa S; Fujiwara T
    Expert Opin Biol Ther; 2013 Nov; 13(11):1569-83. PubMed ID: 24107178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular targeting of gene therapy and radiotherapy.
    Weichselbaum RR; Kufe DW; Advani SJ; Roizman B
    Acta Oncol; 2001; 40(6):735-8. PubMed ID: 11765068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic administration of a PEGylated adenovirus vector with a cancer-specific promoter is effective in a mouse model of metastasis.
    Yao X; Yoshioka Y; Morishige T; Eto Y; Watanabe H; Okada Y; Mizuguchi H; Mukai Y; Okada N; Nakagawa S
    Gene Ther; 2009 Dec; 16(12):1395-404. PubMed ID: 19641532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant transcription from an unrelated promoter can result in MDR-1 expression following drug selection in vitro and in relapsed lymphoma samples.
    Huff LM; Wang Z; Iglesias A; Fojo T; Lee JS
    Cancer Res; 2005 Dec; 65(24):11694-703. PubMed ID: 16357181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiation-guided gene therapy of cancer.
    Han Z; Wang H; Hallahan DE
    Technol Cancer Res Treat; 2006 Aug; 5(4):437-44. PubMed ID: 16866574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Properties of a telomerase-specific Cre/Lox switch for transcriptionally targeted cancer gene therapy.
    Bilsland AE; Fletcher-Monaghan A; Keith WN
    Neoplasia; 2005 Nov; 7(11):1020-9. PubMed ID: 16331888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear basic fibroblast growth factor regulates triple-negative breast cancer chemo-resistance.
    Li S; Payne S; Wang F; Claus P; Su Z; Groth J; Geradts J; de Ridder G; Alvarez R; Marcom PK; Pizzo SV; Bachelder RE
    Breast Cancer Res; 2015 Jul; 17(1):91. PubMed ID: 26141457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene therapy vectors containing CArG elements from the Egr1 gene are activated by neutron irradiation, cisplatin and doxorubicin.
    Greco O; Powell TM; Marples B; Joiner MC; Scott SD
    Cancer Gene Ther; 2005 Jul; 12(7):655-62. PubMed ID: 15818381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenovirus-mediated heat-activated antisense Ku70 expression radiosensitizes tumor cells in vitro and in vivo.
    Li GC; He F; Shao X; Urano M; Shen L; Kim D; Borrelli M; Leibel SA; Gutin PH; Ling CC
    Cancer Res; 2003 Jun; 63(12):3268-74. PubMed ID: 12810658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heat-inducible transgene expression system incorporating a positive feedback loop of transcriptional amplification for hyperthermia-induced gene therapy.
    Yamaguchi M; Ito A; Okamoto N; Kawabe Y; Kamihira M
    J Biosci Bioeng; 2012 Oct; 114(4):460-5. PubMed ID: 22658541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CRE-palindrome oligonucleotide as a transcription factor decoy and an inhibitor of tumor growth.
    Cho-Chung YS
    Antisense Nucleic Acid Drug Dev; 1998 Apr; 8(2):167-70. PubMed ID: 9593058
    [No Abstract]   [Full Text] [Related]  

  • 34. A novel oncolytic adenovirus expressing Escherichia coli cytosine deaminase exhibits potent antitumor effect on human solid tumors.
    Zhang J; Wei F; Wang H; Li H; Qiu W; Ren P; Chen X; Huang Q
    Cancer Biother Radiopharm; 2010 Aug; 25(4):487-95. PubMed ID: 20735209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opportunities and challenges in combination gene cancer therapy.
    Nastiuk KL; Krolewski JJ
    Adv Drug Deliv Rev; 2016 Mar; 98():35-40. PubMed ID: 26724249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer gene therapy.
    Douglas JT
    Technol Cancer Res Treat; 2003 Feb; 2(1):51-64. PubMed ID: 12625754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-specific gene delivery using genetically engineered bacteria.
    Theys J; Barbé S; Landuyt W; Nuyts S; Van Mellaert L; Wouters B; Anné J; Lambin P
    Curr Gene Ther; 2003 Jun; 3(3):207-21. PubMed ID: 12762480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The DNA damage response: implications for tumor responses to radiation and chemotherapy.
    Goldstein M; Kastan MB
    Annu Rev Med; 2015; 66():129-43. PubMed ID: 25423595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
    Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiation to control transgene expression in tumors.
    Marignol L; Coffey M; Hollywood D; Lawler M
    Cancer Biol Ther; 2007 Jul; 6(7):1005-12. PubMed ID: 17611403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.